Health
Bispecific IgG switch off SARS-CoV-2 escape variants – European Biotechnology News
A bispecific antibody designed by a Swiss-Czech research team suppressed viral escape of SARS-CoV-2 variants in animals.
A bispecific antibody designed by a Swiss-Czech research team suppressed viral escape of SARS-CoV-2 variants in animals. The team headed by Daniel Ruzek or Luca Varani from the University of Bellinzona and the Czech Academy of Sciences targeted two binding sites within the receptor binding domain (RBD) of the SARS-CoV-2 Spike (S) protein to prevent generation of viral survivors. The engineered bispecific, IgG1-like molecule (CoV-X2) based on two antibodies derived from COVID-19 convalescent donors,…
-
Noosa News19 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News21 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News17 hours agoFranz Ferdinand: Australian Tour 2025
-
Business17 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week